- Home
- FFIN vs INDV Comparison
FFIN vs INDV Comparison
Compare FFIN & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | FFIN | INDV |
|---|---|---|
| Founded | 1890 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.9B | 4.7B |
| IPO Year | 1994 | 2014 |
Fundamental Metrics
Financial Performance| Metric | FFIN | INDV |
|---|---|---|
| Price | $34.83 | $38.94 |
| Analyst Decision | Hold | |
| Analyst Count | 2 | 0 |
| Target Price | ★ $36.50 | N/A |
| AVG Volume (30 Days) | 742.5K | ★ 2.1M |
| Earning Date | 04-16-2026 | 06-08-2026 |
| Dividend Yield | ★ 2.39% | N/A |
| EPS Growth | 13.46 | ★ 8100.00 |
| EPS | 1.00 | ★ 1.67 |
| Revenue | N/A | ★ $1,239,000,000.00 |
| Revenue This Year | $17.16 | N/A |
| Revenue Next Year | $6.61 | N/A |
| P/E Ratio | $34.26 | ★ $23.07 |
| Revenue Growth | N/A | ★ 4.29 |
| 52 Week Low | $28.12 | $22.22 |
| 52 Week High | $38.12 | $42.81 |
Technical Indicators
Market Signals| Indicator | FFIN | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 50.92 | 48.16 |
| Support Level | $33.92 | $38.47 |
| Resistance Level | $35.00 | $41.83 |
| Average True Range (ATR) | 0.57 | 1.61 |
| MACD | -0.11 | -0.17 |
| Stochastic Oscillator | 46.30 | 55.43 |
Price Performance
Historical ComparisonAbout FFIN First Financial Bankshares Inc.
First Financial Bankshares Inc is a financial and bank holding company. The company operates one line of business (community banking) located in a single geographic area (Texas). The company conducts a full-service commercial banking business through its subsidiaries. The loan portfolio segments of the company include Commercial and Industrial, Municipal, Agricultural, Construction and Development, Farm, Non-Owner Occupied and Owner Occupied Commercial Real Estate, Residential, Consumer Auto and Consumer Non-Auto.
About INDV Indivior PLC
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).